The impact of BMI extremes on disease-free survival and overall survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Naffouje, Samer A; Tulla, Kiara A; Khalaf, Zaynab; Salti, George I

Naffouje, Samer A; Tulla, Kiara A; Khalaf, Zaynab; Salti, George I.

Afiliação

Naffouje SA; Department of General Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
Tulla KA; Department of General Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
Khalaf Z; College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Salti GI; Division of Surgical Oncology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.

J Gastrointest Oncol ; 10(2): 194-202, 2019 Apr.

Article em En | MEDLINE | ID: mdl-31032085

Palavras-chave

Body mass index (BMI); cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS and HIPEC); disease-free survival (DFS); overall survival (OS)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google